Yakult Honsha : Executive Summary of Consolidated Financial Results for the Year Ended March 31, 2021
May 14, 2021 at 10:15 am EDT
Share
Executive Summary of Consolidated Financial Results
for the year ended March 31, 2021
Yakult Honsha Co., Ltd.
May 14, 2021
General outline of
Consolidated financial results
◆Total【Decrease in sales and profit 】
◆Food and Beverages (Japan)
【Decrease in sales and increase profit 】
・Dairy products : The effect of new products (Yakult 1000 etc.) and increase in the number of bottles sold.
・Beverages etc. : Decrease in the number of bottles sold due to the novel coronavirus infection.
◆Food and Beverages (Overseas)
【Decrease in sales and profit】
・Decrease in sales volume.
・Decrease in sales and profit due to appreciation of yen etc.
◆Pharmaceuticals
【Decrease in sales and increase profit 】
・Impact by NHI drug price revision.
・Decrease in expenses due to refraining from sales activities.
- 1 -
Consolidated financial results (1)
Billion yen
FY2020
FY2019
Difference
(2020.4-2021.3)
(2019.4-2020.3)
Year-on-Year
Net sales
385.7
406.0
(20.2)
95.0%
Fx impact (11.2)
Operating profit
43.6
45.6
(1.9)
95.7%
Fx impact (2.3)
Ordinary profit
57.6
58.4
(0.8)
98.5%
Fx impact (2.8)
Profit attributable to
39.2
39.7
(0.4)
98.8%
owners of parent
Fx impact (1.7)
Basic earnings
( yen)
( yen)
( yen)
per share
244.85
248.04
(3.19)
98.7%
Operating
11.3%
11.2%
+ 0.1
-
profit margin
- 2 -
Consolidated Statement of Income
Billion yen
FY2020
FY2019
Difference
FY2020
FY2019
Difference
(2020.4-2021.3)
(2019.4-2020.3)
(2020.4-2021.3)
(2019.4-2020.3)
Net sales
385.7
406.0
(20.2)
Gain on sales of
0.2
0.1
0.0
Cost of sales
158.8
171.3
(12.4)
non-current assets
Gross profit
226.8
234.6
(7.8)
Gain on sales of
3.7
2.5
1.2
investment securities
Selling, general and
183.1
188.9
(5.8)
Others
0.5
0.0
0.4
administrative expenses
Operating profit
43.6
45.6
(1.9)
Extraordinary income
4.5
2.7
1.8
Interest income
3.7
5.4
(1.7)
Loss on retirement
0.4
0.7
(0.3)
of non-current assets
Dividend income
2.0
2.0
(0.0)
Impairment loss
0.4
0.4
(0.0)
Share of profit of entities accounted
3.9
5.0
(1.1)
Loss on valuation of
0.6
0.9
(0.3)
for using equity method
investment securities
Foreign exchange gains
2.6
-
2.6
Expense related to
1.1
-
1.1
a novel coronavirus
Others
3.1
2.1
0.9
Others
0.1
0.2
(0.1)
Non-operating income
15.3
14.7
0.6
Extraordinary losses
2.7
2.4
0.3
Interest expenses
0.7
0.8
(0.1)
Profit before income taxes
59.3
58.7
0.6
Others
0.7
1.0
(0.3)
Incometaxes
15.8
13.8
1.9
Profit
43.4
44.8
(1.3)
Non-operating expenses
1.4
1.9
(0.4)
Profit attributable to
4.2
5.1
(0.8)
non-controlling interests
Ordinary profit
57.6
58.4
(0.8)
Profit attributable to owners
39.2
39.7
(0.4)
of parent
- 3 -
Consolidated financial results (2)
Total assets Net assets Net assets per share Equity-to-assetratio ROE ROA
Billion yen
As of Mar. 31 As of Mar. 31
Difference
(FY2020)
(FY2019)
Year-on-Year
635.1
627.8
+ 7.2
101.2%
439.7
412.0
+ 27.6
106.7%
( yen)
( yen)
( yen)
2,523.81
2,330.58
+ 193.23
108.3%
63.8%
59.5%
+ 4.3
―
10.1%
10.9%
(0.8)
―
9.1%
9.4%
(0.3)
―
- 4 -
Attachments
Original document
Permalink
Disclaimer
Yakult Honsha Co. Ltd. published this content on 12 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 May 2021 14:14:05 UTC.
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.